| abstract |
The present invention is concerned with pharmaceutical combinations ofnamlodipine or a pharmaceutically acceptable acid addition salt thereof andnatorvastatin or a pharmaceutically acceptable salt thereof, kits containing suchncombinations and methods of using such combinations to treat subjectsnsuffering from angina pectoris, atherosclerosis, combined hypertension andnhyperlipidaemia and to treat subjects presenting with symptoms of cardiacnrisk, including humans. This invention also relates to additive and synergisticncombinations of amlodipine and atorvastatin whereby these synergisticncombinations are useful in treating subjects suffering from angina pectoris,natherosclerosis, combined hypertension and hyperlipidaemia and subjectsnpresenting with symptoms of cardiac risk, including humans. |